SG11202104015YA - Therapeutic agent for cartilage disorder - Google Patents
Therapeutic agent for cartilage disorderInfo
- Publication number
- SG11202104015YA SG11202104015YA SG11202104015YA SG11202104015YA SG11202104015YA SG 11202104015Y A SG11202104015Y A SG 11202104015YA SG 11202104015Y A SG11202104015Y A SG 11202104015YA SG 11202104015Y A SG11202104015Y A SG 11202104015YA SG 11202104015Y A SG11202104015Y A SG 11202104015YA
- Authority
- SG
- Singapore
- Prior art keywords
- therapeutic agent
- cartilage disorder
- cartilage
- disorder
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018200866 | 2018-10-25 | ||
| PCT/JP2019/042015 WO2020085506A1 (ja) | 2018-10-25 | 2019-10-25 | 軟骨疾患の治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104015YA true SG11202104015YA (en) | 2021-05-28 |
Family
ID=70331194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104015YA SG11202104015YA (en) | 2018-10-25 | 2019-10-25 | Therapeutic agent for cartilage disorder |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210386823A1 (ja) |
| EP (1) | EP3865179A4 (ja) |
| JP (1) | JP7448126B2 (ja) |
| KR (1) | KR20210082478A (ja) |
| CN (1) | CN113423466A (ja) |
| AU (1) | AU2019367943A1 (ja) |
| BR (1) | BR112021007732A2 (ja) |
| CA (1) | CA3117107A1 (ja) |
| IL (1) | IL282377A (ja) |
| MX (1) | MX2021004758A (ja) |
| SG (1) | SG11202104015YA (ja) |
| WO (1) | WO2020085506A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024005133A1 (ja) * | 2022-06-30 | 2024-01-04 | 国立大学法人大阪大学 | 半月板の治療薬 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040156851A1 (en) * | 2002-11-20 | 2004-08-12 | Critical Therapeutics, Inc. | HMGB1 combination therapies |
| BRPI0514835A (pt) * | 2004-09-03 | 2008-06-24 | Creabilis Therapeutics Spa | variante de polipetìdeo de box de domìnio de ligação por alta afinidade de hmbg1 humano e/ou não humano ou de fragmento biologicamente ativo de box-a de hmgb1, molécula de ácido nucléico, uso, composição farmacêutica e dispositivo médico |
| CN101528266B (zh) * | 2006-09-15 | 2012-11-07 | 克雷毕里斯治疗股份公司 | Hmgb1的a盒和hmgb1的a盒变体的聚合体缀合物 |
| JP2010503630A (ja) * | 2006-09-15 | 2010-02-04 | クレアビリス・セラピューティクス・エスピーエー | ＨＭＧＢ１のＢｏｘ−ＡおよびＨＭＧＢ１のＢｏｘ−Ａ変異体のポリマー複合体 |
| RU2571230C2 (ru) * | 2008-04-30 | 2015-12-20 | Дженомикс Ко., Лтд. | Способ сбора функциональных клеток in vivo с высокой эффективностью |
| DK2703487T3 (en) * | 2011-04-26 | 2018-09-10 | Genomix Co Ltd | TIME TO INDUCTION Tissue Regeneration and its Use |
| AU2013335684B2 (en) | 2012-10-25 | 2017-06-29 | Osaka University | Novel method for treating cardiac infarction using HMGB1 fragment |
| JP6253590B2 (ja) * | 2012-10-25 | 2017-12-27 | 株式会社ジェノミックス | Ｈｍｇｂ１断片を利用した脊髄の損傷に対する新規治療法 |
| JP7182162B2 (ja) | 2017-01-27 | 2022-12-02 | 株式会社ステムリム | 心筋症、陳旧性心筋梗塞および慢性心不全の治療薬 |
| CN110621331A (zh) | 2017-04-07 | 2019-12-27 | 斯特姆里姆有限公司 | 纤维化疾病的治疗药物 |
| AU2018257071B2 (en) * | 2017-04-25 | 2021-11-11 | Shionogi & Co., Ltd. | Peptide for inducing regeneration of tissue, and use thereof |
| US11196087B2 (en) | 2017-05-19 | 2021-12-07 | Panasonic Intellectual Property Management Co., Ltd. | Nonaqueous electrolyte containing perfluoropolyether and nitrile compound, and secondary battery including the same |
| WO2019107566A1 (ja) * | 2017-12-01 | 2019-06-06 | 株式会社ステムリム | 外胚葉性間葉系幹細胞およびその製造方法 |
| EP3750553A4 (en) * | 2018-02-08 | 2022-01-12 | Stemrim Inc. | THERAPEUTIC FOR PSORIASIS |
-
2019
- 2019-10-25 JP JP2020552636A patent/JP7448126B2/ja active Active
- 2019-10-25 BR BR112021007732-4A patent/BR112021007732A2/pt unknown
- 2019-10-25 AU AU2019367943A patent/AU2019367943A1/en active Pending
- 2019-10-25 KR KR1020217015301A patent/KR20210082478A/ko unknown
- 2019-10-25 EP EP19875071.3A patent/EP3865179A4/en active Pending
- 2019-10-25 MX MX2021004758A patent/MX2021004758A/es unknown
- 2019-10-25 CA CA3117107A patent/CA3117107A1/en active Pending
- 2019-10-25 WO PCT/JP2019/042015 patent/WO2020085506A1/ja unknown
- 2019-10-25 CN CN201980085703.XA patent/CN113423466A/zh active Pending
- 2019-10-25 US US17/287,636 patent/US20210386823A1/en active Pending
- 2019-10-25 SG SG11202104015YA patent/SG11202104015YA/en unknown
-
2021
- 2021-04-18 IL IL282377A patent/IL282377A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3865179A4 (en) | 2022-07-27 |
| CA3117107A1 (en) | 2020-04-30 |
| MX2021004758A (es) | 2021-08-24 |
| BR112021007732A2 (pt) | 2021-08-03 |
| CN113423466A (zh) | 2021-09-21 |
| US20210386823A1 (en) | 2021-12-16 |
| IL282377A (en) | 2021-06-30 |
| AU2019367943A1 (en) | 2021-05-27 |
| JP7448126B2 (ja) | 2024-03-12 |
| JPWO2020085506A1 (ja) | 2021-09-16 |
| KR20210082478A (ko) | 2021-07-05 |
| WO2020085506A1 (ja) | 2020-04-30 |
| EP3865179A1 (en) | 2021-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201820166D0 (en) | Therapeutic agents | |
| GB201820165D0 (en) | Therapeutic agents | |
| GB201709456D0 (en) | Therapeutic agents | |
| SI3518783T1 (sl) | Naprava za zmanjševanje tkiva | |
| IL282330A (en) | therapeutic compounds | |
| GB201805816D0 (en) | Therapeutic agents | |
| GB201716942D0 (en) | Therapeutic compounds | |
| PL3612475T3 (pl) | Instalacja obróbkowa | |
| ZA202004433B (en) | Therapeutic agent for nervous system disease | |
| GB201700553D0 (en) | Therapeutic agents | |
| IL272271A (en) | A therapeutic agent for fibrosis | |
| IL282377A (en) | Therapeutic aid in cartilage disorders | |
| GB201808150D0 (en) | Therapeutic compounds | |
| SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
| PL3611307T3 (pl) | Układ szynowy | |
| ZA202103582B (en) | Dna-cutting agent | |
| ZA202103578B (en) | Dna-cutting agent | |
| GB201820170D0 (en) | Therapeutic agents | |
| GB201820172D0 (en) | Therapeutic agents | |
| GB201820160D0 (en) | Therapeutic agents | |
| GB201820162D0 (en) | Therapeutic agents | |
| GB201820164D0 (en) | Therapeutic agents | |
| GB201820168D0 (en) | Therapeutic agents | |
| GB201811753D0 (en) | Therapeutic agents | |
| GB201811467D0 (en) | Therapeutic agents |